Progressive Neuroendocrine Tumors of pancreatic origin

Also known as: Pancreatic origin Progressive Neuroendocrine Tumors

Drug	Drug Name	Drug Description
DB01590	Everolimus	A mammalian target of rapamycin (mTOR) kinase inhibitor used to treat various types of malignancies.

Drug	Drug Name	Target	Type
DB01590	Everolimus	Serine/threonine-protein kinase mTOR	target
DB01590	Everolimus	Cytochrome P450 3A4	enzyme
DB01590	Everolimus	Solute carrier organic anion transporter family member 1B1	transporter
DB01590	Everolimus	Solute carrier organic anion transporter family member 1B3	transporter
DB01590	Everolimus	Solute carrier organic anion transporter family member 1A2	transporter
DB01590	Everolimus	Cytochrome P450 2D6	enzyme
DB01590	Everolimus	P-glycoprotein 1	transporter

Drug	Drug Name	Phase	Status	Count